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ABSTRACT 
THE INFLUENZA/H1N1 VIRUS HAS CAUSED HAZARD IN THE PUBLIC HEALTH OF MANY COUNTRIES. HENCE, EXISTING 
INFLUENZA DRUGS COULD NOT COPE WITH H1N1 INFECTION DUE TO THE HIGH MUTATION RATE OF THE VIRUS. IN THIS 
RESPECT, NEW METHOD TO BLOCK THE VIRUS WAS DEVISED. THE POLYMERASE PAC-PB1N ENZYME IS RESPONSIBLE FOR 
THE REPLICATION OF H1N1 VIRUS. THUS, NOVEL INHIBITORS WERE DEVELOPED TO WARD OFF THE FUNCTIONALITY OF 
THE ENZYME. IN THIS RESEARCH, CYCLIC PEPTIDES HAS BEEN CHOSEN TO INHIBIT PAC-PB1N DUE TO ITS PROVEN 
STABILITY IN REACHING THE DRUG TARGET. THUS, COMPUTATIONAL METHOD FOR ELUCIDATING THE MOLECULAR 
INTERACTION BETWEEN CYCLIC PEPTIDES AND PAC-PB1N HAS BEEN DEVELOPED BY USING THE LIGX TOOLS FROM 
MOE 2008.10 SOFTWARE. THE TOOLS COULD RENDER THE BINDINGS THAT INVOLVED IN THE INTERACTIONS. THE 
INTERACTIONS BETWEEN INDIVIDUAL AMINO ACID IN THE INHIBITOR AND ENZYME COULD BE SEEN AS WELL. THUS, THE 
PEPTIDE SEQUENCES OF CKTTC AND CKKTC WERE CHOSEN AS THE LEAD COMPOUNDS. IN THIS END, THE FEASIBILITY 
OF CYCLIC PEPTIDES TO ACT AS DRUG CANDIDATE FOR H1N1 COULD BE EXPOSED BY THE 2D AND 3D MODELING OF THE 
MOLECULAR INTERACTIONS. 
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Introduction 
WHO has declared that Influenza A/H1N1 as serious treat in the public health (WHO, 2014). Therefore, drugs 
must be developed to overcome the infection. Currently, scientist is developing H1N1 drugs based on molecular biology 
information system (Chang, Huang, & Chen, 2011). Influenza A H1N1 virus carried eight negative-strand RNA genome 
segments, and each one was bound by the viral encoded RNA-dependent RNA polymerase (RdRp) complex (Larsen et 
al., 2014).The heterotrimeric complex of PA, PB1, and PB2 are working together as RNA polymerase enzyme that 
responsible for the reproduction of Viral RNA (Y. Liu, Lou, Bartlam, & Rao, 2009). 
The influenza virus polymerase can replicate de novo its viral genome RNA through two steps. The replication 
step involves synthesis of complementary RNA (cRNA) from a viral RNA (vRNA) template, followed by synthesis of 
vRNA from cRNA to complete the genomic RNA replication process (Y. Liu et al., 2009). The transcription step 
involves viral mRNA transcription from vRNA by snatching capped primers from nascent host cell mRNA (Y. Liu et al., 
2009). 
In previous research, viral RNA synthesis could be blocked by the specific inhibition of viral polymerase 
complex formation by using small peptide that bound to the protein-protein interaction domain that responsible for 
hetero-oligomerization amongst the individual subunits. The small peptide was consisted of 25 amino acid corresponding 
to the PA-binding domain of PB1 that inhibits the polymerase activity of influenza A virus and obstruct the viral spread 
(Ghanem et al., 2007). Thus, the peptide sequence nomenclature is always following the one-letter system from IUPAC-
IUB (IUPAC-IUB, 1984). In one hand, Ribavirin was also tested as H1N1 drugs in animals (in vivo) and in the clinical 
trials (Rowe et al., 2010; Wilson et al., 1984). In the other hand, the determination of peptide sequence PTLLFL was 
indispensable for warding off influenza A virus (Obayashi, Yoshida, & Park, 2008). The formation of hydrogen bonds of 
the PTLLFL peptide sequence with PBA were conducted by the last two residues (Obayashi et al., 2008). Thus, the 
cyclic peptide has proven as stable and robust drug candidate (Bogdanowich-Knipp, Chakrabarti, Williams, Dillman, & 
Siahaan, 1999; Jois, Tambunan, Chakrabarti, & Siahaan, 1996).Therefore, the objective of this research is to develop 
cyclic peptide-based drug to overcome the H1N1 infection. 
 
Methodology  
The pipeline was prepared in accordance to our methods (A. A. Parikesit, Kinanty, & Tambunan, 2013; A. 
Parikesit, 2010; Tambunan, Parikesit, Dephinto, & Sipahutar, 2014; Tambunan, Zahroh, Utomo, & Parikesit, 2014).  The 
Polymerase A and B1 sequences were retrieved from NCBI database (NCBI, 2013; Wheeler et al., 2007). Then, the 
sequences were computed with multiple sequences alignment methods by using ClustalW tools (Thompson, Gibson, & 
Higgins, 2002). The template was identified by using SWISS-MODEL server (Arnold, Bordoli, Kopp, & Schwede, 
2006). The cyclic peptide ligands were constructed by using ACD/PhysChem Suite 12.0 with peptide sequence of 
PTLLFL and Ribavirin were applied as standards (Obayashi et al., 2008; Rowe et al., 2010; Spessard, 1998). Thus, the 
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ligand-enzyme interactions were analyzed by using docking method and LigX tool of MOE 2008.10 software (Dias & de 
Azevedo, 2008; Tambunan, Parikesit, Prasetia, & Kerami, 2013).  
 
Results and Discussion  
Table 1, it shows the calculated free binding energy (ΔGbinding) of flexible-ligand docking simulation from the 
best ligand. Free energy of binding for all the designed ligands was lower than the comparative ligand (ribavirin and 
peptide sequence of PTLLFL) (Guu, Dong, Wittung-Stafshede, & Tao, 2008). The ligand free energy of the peptide 
sequences CKTTC, CKKTC, PTLLFL and ribavirin were negative value, respectively, -20.9946, -18.0293, -14.4066, and 
-9.7573 kcal/mol. The negative and low value of ΔGbinding indicated the strong favorable bond between enzyme and 
ligand. 
Table 1. The ligand Free energy of binding and Ki results calculated using MOE 2008.10. 
Ligand 
Estimated ΔG 
(kcal/mol) 
Estimated Inhibition 
Constant/Ki (µM) 
Peptide Sequence of 
CKTTC 
-20.9946 
1.9x10-7 
 
Peptide Sequence of 
CKKTC 
-18.0293 2.9x10-4 
Peptide Sequence of 
PTLLFL 
-14.4066  5.5x10-1 
Ribavirin  -9.7573 0.52 
 
These ΔGbinding values were parallel to the Ki values observed in Table 1. Ligand CKTTC and CKKTC showed 
the lowest Ki value, it could be estimated that the reaction equilibrium shifted to the complex formation. In general, all 
calculated Ki values were small (within micromolar range), indicating the formation of stable enzyme-ligand complexes. 
Every ligand showed reasonably low internal energy. It indicated that the docked conformation of the ligands were in 
their most favorable conformations (Zavodszky & Kuhn, 2005).  
The substitution of Molecular Mechanics Generalized Born surface area (MM-GBSA) with the generalized 
Born (GB) approximate model of electrostatics in water was much more conducive for the PB electrostatics (Cui et al., 
2008). It is already proven that MM-GBSA could effectively compute the binding free energy atomic/group 
contributions (Cui et al., 2008; Gohlke, Kiel, & Case, 2003). In this docking simulation, we utilized gas phase solvation 
(MacKerell et al., 1998). 
In Table 2, we presented residue contact of ligand peptide sequences of CKTTC, CKKTC, PTLLFL, and 
ribavirin. Red residue indicated amino acid residues which have highly important role of the interaction between the 
polymerase A and B1. Ligand CKTTC and CKKTC had residue contact with polymerase A (Gln 408, Glu 623) and 
polymerase B (Asp 2). The other side, residu contacts were occurred only in polymerase B1(Asp 2) for the ligand 
ribavirin and PTLLFL. 
 
Table 2. The residue contact of ligands in molecular docking simulation. 
Ligand 
Residue contact 
PA Score (%) PB1 Score (%) 
Peptide Sequence of 
CKTTC 
Gln 408 43.6 
Asp 2 90.8 Glu 623 64.0 
Asn 708 45.3 
Peptide Sequence of 
CKKTC 
Gln 408 21.1 
Asp 2 
12.3 
Glu 623 49.5 32.4 
  74.0 
Peptide Sequence of 
PTLLFL 
Ser 405 24.7 Asp 2 77.6 
Ribavirin Ser 709 18.1 Asp 2 36.4 
 
 Ligand CKTTC and CKKTC are good residue contact because Gln 408 plays an important role for PB1 
binding. The Gln 408 and Asn 412 always form the hydrogen bonds with Asn 4 and Val 3 from PB1 respectively. At the 
same time, the residue 2-4 of PB1 tends to form β sheets and the regular hydrogen bonds between β sheets. During 
recognition process between PA and PB1, these interactions are important to the orientation of PB1 (H. Liu & Yao, 
2010). The residue from 619-623 is very important for PA binding, which is in good agreement with in vitro binding 
assay results that the deletion of residues 619-630 for PA largely weakens the binding ability of PA to PB1 (Obayashi et 
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al., 2008). If we compare all of the ligand, ligand CKTTC and CKKTC are the best ligand. Hopefully, this ligand can 
block interaction between PA and PB1.  
In Figure 1, we presented the ligand-receptor interaction diagrams. This is a depiction of relatively strong 
connections among hydrogen bonds as well as electrostatic or charge-transfer interaction between a ligand and the 
residue protein.  The diagrams were elucidated by using LigX tool of MOE 2008.10 (Qamar et al., 2014). 
 
 
a)   
b)  
 
c)   
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Figure1. Interaction plots illustrating between ligand and the respective amino acid residues. CKTTC (a), CKKTC 
(b),standard ligand PTLLFL (c), ribavirin (d). 
 
Conclusions 
It is shown in the Figure 1 that the interaction complexity of the ligand-enzyme could be a contributing factor to 
develop peptide sequences of CKTTC and CKKTC as H1N1 drug candidates. 
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